ClinicalTrials.govpublic full text
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Dose-Response Relationship of Multiple Doses of GSK2269557 Administered as a Dry Powder to Chronic Obstructive Pulmonary Disease (COPD) Patients
pulmonary disease, chronic obstructive, pi3kd, pharmacodynamics, dry powder inhaler, gsk2269557, safety, copd subjects, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 878954
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.